These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1655378)

  • 1. [Osteoporosis in Crohn disease].
    Müller M; Jenss H
    Dtsch Med Wochenschr; 1991 Oct; 116(41):1574. PubMed ID: 1655378
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoporosis in patients with inflammatory bowel disease.
    Bernstein CN
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):152-6. PubMed ID: 16469673
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoporosis: calcium and vitamin D3 are the basis for prevention and therapy. A national disease that should not be].
    Orthopade; 1994 Jun; 23(3 Suppl [osteopor]):1-4. PubMed ID: 9211673
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
    Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
    Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.
    Vogelsang H; Ferenci P; Resch H; Kiss A; Gangl A
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):609-14. PubMed ID: 8590154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteoporotic risk in Crohn's disease].
    Di Prima L; Sferrazza C; Avila D; Pirrone G; Cappello G; Di Lorenzo G; Carroccio A; Rini GB; Di Fede G
    Recenti Prog Med; 2005 May; 96(5):254-60. PubMed ID: 15977658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone demineralization in Crohn's disease, its diagnosis, therapy and prevention].
    Kocián J; Kociánová J
    Cas Lek Cesk; 1999 Aug; 138(17):522-4. PubMed ID: 10566230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osseous demineralization and diseases of the alimentary tract in adults].
    de Sèze S; Dreyfus P; Selmes J
    Cah Coll Med Hop Paris; 1969 Oct; 10(12):963-70. PubMed ID: 4189430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
    Lems WF; Jacobs JW; Netelenbos JC; Dijkmans BA; Bijlsma JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1904-8. PubMed ID: 9856175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of early post-menopausal bone mineral loss. Controlled 2-year study of 315 women].
    Christiansen C; Christensen MS; Jensen J; McNair P; Hagen C; Stocklund KE; Transbøl I
    Ugeskr Laeger; 1980 Oct; 142(44):2896-901. PubMed ID: 6255653
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current approaches to the prevention and treatment of osteoporosis: the role of calcium and vitamin D].
    Nasonov EL; Skripnikova IA; Gukasian D
    Klin Med (Mosk); 1997; 75(9):9-15. PubMed ID: 9432553
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease.
    Roblin X; Phelip JM; Genevois M; Ducros V; Bonaz B
    Aliment Pharmacol Ther; 2007 Apr; 25(7):797-804. PubMed ID: 17373918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis.
    Dear KL; Compston JE; Hunter JO
    Clin Nutr; 2001 Dec; 20(6):541-6. PubMed ID: 11884003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do vitamin D3 and analogs have an antipsoriatic effect?].
    Mrowietz U
    Dtsch Med Wochenschr; 1999 Nov; 124(47):1437. PubMed ID: 10605426
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoporosis and calcium: to supplement or not to supplement.
    Dubovsky J
    Ala J Med Sci; 1987 Oct; 24(4):431-5. PubMed ID: 3310710
    [No Abstract]   [Full Text] [Related]  

  • 16. [Course in a case of extensive resection of the small bowel in Crohn's disease. Dietetic treatment and consequences on phospho-calcic metabolism].
    Fiasse R; Kestens PJ; de Raeymaeker L; Huaux JP; Nagant de Deuxchaisnes C
    Ann Chir; 1970 May; 24(9):559-63. PubMed ID: 5429598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
    MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylaxis against bone loss in Kock reservoir patients with reduced glomerular filtration rate.
    Jonsson O; Herlitz H; Lindholm E; Lindstedt G; Pazooki D; Törnqvist H; Mellström D
    Scand J Urol Nephrol; 2005; 39(3):200-5. PubMed ID: 16118090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of calcium in osteoporosis].
    Rico H; Revilla M
    An Med Interna; 1994 Dec; 11(12):604-9. PubMed ID: 7734670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.